Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 798 publications

Myasthenia Gravis as a Manifestation of Aicardi-Goutières Syndrome Due to a SAMHD1 Variant Successfully Treated With Baricitinib.

Myasthenia Gravis as a Manifestation of Aicardi-Goutières Syndrome Due to a SAMHD1 Variant Successfully Treated With Baricitinib.

Journal: Cureus
Published: September 02, 2025

Endothelial Cell Expression of STING V154M Gain-of-Function Mutation Delays the Resolution of UVB-induced Skin Injury.

Endothelial Cell Expression of STING V154M Gain-of-Function Mutation Delays the Resolution of UVB-induced Skin Injury.

Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025

Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature.

Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature.

Journal: Journal of clinical medicine
Published: July 14, 2025

Skin manifestations of SARS-CoV-2 infection and its vaccination.

Skin manifestations of SARS-CoV-2 infection and its vaccination.

Journal: Current opinion in immunology
Published: June 24, 2025

Comparative histopathologic analysis of COVID-19-associated pseudo-chilblains ("COVID-toes"), with idiopathic pernio, and chilblains lupus erythematosus.

Comparative histopathologic analysis of COVID-19-associated pseudo-chilblains ("COVID-toes"), with idiopathic pernio, and chilblains lupus erythematosus.

Journal: JAAD international
Published: June 16, 2025

Successful treatment of refractory chilblain lupus erythematosus with bosentan.

Successful treatment of refractory chilblain lupus erythematosus with bosentan.

Journal: Rheumatology (Oxford, England)
Published: May 08, 2025

TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupus.

TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupus.

Journal: The British journal of dermatology
Published: April 30, 2025

Chilblains With Tumid Lupus Features in a Patient With Sjögren's Syndrome: A Case Report.

Chilblains With Tumid Lupus Features in a Patient With Sjögren's Syndrome: A Case Report.

Journal: Cureus
Published: April 02, 2025

Chilblain lupus induced by infliximab therapy.

Chilblain lupus induced by infliximab therapy.

Journal: Rheumatology advances in practice
Published: March 31, 2025

Delayed Diagnosis of Aicardi-Goutières Syndrome in a 10-Year-Old Female Child With TREX1 Mutation: A Case Report.

Delayed Diagnosis of Aicardi-Goutières Syndrome in a 10-Year-Old Female Child With TREX1 Mutation: A Case Report.

Journal: Cureus
Published: February 26, 2025

Comment on "Trends and Associations of Chilblains Prevalence with Connective Tissue Diseases, Including COVID-19 Incidence" [Letter].

Comment on "Trends and Associations of Chilblains Prevalence with Connective Tissue Diseases, Including COVID-19 Incidence" [Letter].

Journal: Clinical, cosmetic and investigational dermatology
Published: February 07, 2025

An Evidence-Based Review of Perniosis (Chilblains): Therapeutic Strategies and Integration With Raynaud's Syndrome Management.

An Evidence-Based Review of Perniosis (Chilblains): Therapeutic Strategies and Integration With Raynaud's Syndrome Management.

Journal: International journal of dermatology
Published: February 06, 2025
Showing 1-12 of 798

Last Updated: 10/31/2025